Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1995 1
1997 1
2002 2
2003 4
2004 2
2005 6
2006 2
2007 3
2008 5
2009 4
2010 6
2011 20
2012 13
2013 25
2014 44
2015 36
2016 30
2017 29
2018 14
2019 24
2020 24
2021 36
2022 38
2023 37
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Fasching PA, Hack CC, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, Wolf C, Kolberg HC, Brucker C, Janni W, Dall P, Schneeweiss A, Marme F, Sütterlin MW, Ruebner M, Theuser AK, Kellner S, Hofmann NM, Böhm S, Almstedt K, Lück HJ, Schmatloch S, Kalder M, Uleer C, Jurhasz-Böss I, Hanf V, Jackisch C, Müller V, Rack B, Belleville E, Wallwiener D, Rody A, Rauh C, Bayer CM, Uhrig S, Goossens C, Huebner H, Brucker SY, Hein A, Fehm TN, Häberle L. Fasching PA, et al. Among authors: aktas b. Eur J Cancer. 2024 Sep;209:114239. doi: 10.1016/j.ejca.2024.114239. Epub 2024 Jul 21. Eur J Cancer. 2024. PMID: 39059184 Free article.
Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study.
Falconer H, Norberg-Hardie A, Salehi S, Alfonzo E, Weydandt L, Dornhöfer N, Wolf B, Höckel M, Aktas B. Falconer H, et al. Among authors: aktas b. EClinicalMedicine. 2024 Jun 20;73:102696. doi: 10.1016/j.eclinm.2024.102696. eCollection 2024 Jul. EClinicalMedicine. 2024. PMID: 39007068 Free PMC article.
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast Cancer.
Würstlein R, Kolberg HC, Hartkopf AD, Fehm TN, Welslau M, Schütz F, Fasching PA, Janni W, Witzel I, Thomssen C, Krückel A, Belleville E, Lüftner D, Untch M, Thill M, Hörner M, Tesch H, Ditsch N, Lux MP, Aktas B, Banys-Paluchowski M, Taran FA, Wöckel A, Harbeck N, Stickeler E, Bartsch R, Schneeweiss A, Ettl J, Krug D, Müller V. Würstlein R, et al. Among authors: aktas b. Geburtshilfe Frauenheilkd. 2024 May 29;84(6):529-540. doi: 10.1055/a-2300-5326. eCollection 2024 Jun. Geburtshilfe Frauenheilkd. 2024. PMID: 38884028 Free PMC article.
The immune system in Parkinson's disease: what we know so far.
Roodveldt C, Bernardino L, Oztop-Cakmak O, Dragic M, Fladmark KE, Ertan S, Aktas B, Pita C, Ciglar L, Garraux G, Williams-Gray C, Pacheco R, Romero-Ramos M. Roodveldt C, et al. Among authors: aktas b. Brain. 2024 Oct 3;147(10):3306-3324. doi: 10.1093/brain/awae177. Brain. 2024. PMID: 38833182 Free PMC article. Review.
382 results